These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7462689)

  • 1. Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen.
    Kasper DL; Onderdonk AB; Reinap BG; Linberg AA
    J Infect Dis; 1980 Nov; 142(5):750-6. PubMed ID: 7462689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
    Kasper DL
    J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
    J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface antigens as virulence factors in infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
    Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation.
    Kasper DL; Onderdonk AB; Bartlett JG
    J Infect Dis; 1977 Dec; 136(6):789-95. PubMed ID: 336801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical characterization of the outer membrane complex of Bacteroides fragilis subspecies fragilis.
    Kasper DL; Seiler MW
    J Infect Dis; 1975 Oct; 132(4):440-50. PubMed ID: 810521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the common immunodominant antigenic determinant in the lipopolysaccharide of Bacteroides fragilis by a monoclonal antibody.
    Linko L; Weintraub A; Arstila P; Pelliniemi LJ; Viljanen MK
    Scand J Immunol; 1987 May; 25(5):469-75. PubMed ID: 2438749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteroides fragilis strains express multiple capsular polysaccharides.
    Pantosti A; Tzianabos AO; Reinap BG; Onderdonk AB; Kasper DL
    J Clin Microbiol; 1993 Jul; 31(7):1850-5. PubMed ID: 8349763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
    Simon GL; Klempner MS; Kasper DL; Gorbach SL
    J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Bacteroides fragilis strains based on antigen-specific immunofluorescence.
    Weintraub A; Lindberg AA; Kasper DL
    J Infect Dis; 1983 Apr; 147(4):780. PubMed ID: 6341482
    [No Abstract]   [Full Text] [Related]  

  • 12. The cell-surface antigens of Bacteroides thetaiotaomicron.
    Meisel-Mikolajczyk F; Rokosz A; Kaca W
    Eur J Epidemiol; 1989 Dec; 5(4):486-96. PubMed ID: 2514115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological detection of Bacteroides fragilis in clinical samples.
    Patrick S; Stewart LD; Damani N; Wilson KG; Lutton DA; Larkin MJ; Poxton I; Brown R
    J Med Microbiol; 1995 Aug; 43(2):99-109. PubMed ID: 7629860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemistry of the surface carbohydrate antigens of Bacteroides fragilis and definition of a common antigen.
    Poxton IR; Brown R
    J Gen Microbiol; 1986 Sep; 132(9):2475-81. PubMed ID: 2432160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical and immunochemical analyses of Bacteroides fragilis lipopolysaccharides.
    Weintraub A; Larsson BE; Lindberg AA
    Infect Immun; 1985 Jul; 49(1):197-201. PubMed ID: 4008048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro.
    Brubaker JO; Li Q; Tzianabos AO; Kasper DL; Finberg RW
    J Immunol; 1999 Feb; 162(4):2235-42. PubMed ID: 9973499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the surface and somatic antigens of Bacteroides fragilis.
    Elhag KM; Tabaqchali S
    J Hyg (Lond); 1978 Jun; 80(3):439-49. PubMed ID: 649950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a TLR2-stimulating lipoprotein in Bacteroides fragilis JCM 11019 (NCTC 9343).
    Hashimoto M; Eguchi H; Tawaratsumida K; Kirikae T; Suda Y
    Innate Immun; 2013; 19(2):132-9. PubMed ID: 22890547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence of Bacteroides fragilis in vivo.
    Onderdonk AB; Moon NE; Kasper DL; Bartlett JG
    Infect Immun; 1978 Mar; 19(3):1083-7. PubMed ID: 640723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.